Click for best price
Monoclonal antibodies mAbs Biosimilars Market Size, Share 2022
A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are ?equivalent? in terms of quality, efficacy and safety to an innovative reference medicinal product.
This report contains market size and forecasts of Monoclonal antibodies (mAbs) Biosimilars in Global, including the following market information:
Global Monoclonal antibodies (mAbs) Biosimilars Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Monoclonal antibodies (mAbs) Biosimilars market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Erythropoietin (EPO) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Monoclonal antibodies (mAbs) Biosimilars include Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, 3SBio, Accord Healthcare, AET Biotech, Allergan and Amega Biotech. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Monoclonal antibodies (mAbs) Biosimilars companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Monoclonal antibodies (mAbs) Biosimilars Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Monoclonal antibodies (mAbs) Biosimilars Market Segment Percentages, by Type, 2021 (%)
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others
Global Monoclonal antibodies (mAbs) Biosimilars Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Monoclonal antibodies (mAbs) Biosimilars Market Segment Percentages, by Application, 2021 (%)
Anti-Cancer
Anti-Inflammatory/Autoimmune
Global Monoclonal antibodies (mAbs) Biosimilars Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Monoclonal antibodies (mAbs) Biosimilars Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monoclonal antibodies (mAbs) Biosimilars revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Monoclonal antibodies (mAbs) Biosimilars revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
| Report Attributes |
Report Details |
| Report Title |
Monoclonal antibodies (mAbs) Biosimilars Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Monoclonal antibodies (mAbs) Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Monoclonal antibodies (mAbs) Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monoclonal antibodies (mAbs) Biosimilars Overall Market Size
2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size: 2021 VS 2028
2.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monoclonal antibodies (mAbs) Biosimilars Players in Global Market
3.2 Top Global Monoclonal antibodies (mAbs) Biosimilars Companies Ranked by Revenue
3.3 Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Companies
3.4 Top 3 and Top 5 Monoclonal antibodies (mAbs) Biosimilars Companies in Global Market, by Revenue in 2021
3.5 Global Companies Monoclonal antibodies (mAbs) Biosimilars Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monoclonal antibodies (mAbs) Biosimilars Players in Global Market
3.6.1 List of Global Tier 1 Monoclonal antibodies (mAbs) Biosimilars Companies
3.6.2 List of Global Tier 2 and Tier 3 Monoclonal antibodies (mAbs) Biosimilars Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Monoclonal antibodies (mAbs) Biosimilars Market Size Markets, 2021 & 2028
4.1.2 Erythropoietin (EPO)
4.1.3 Human Growth Hormone (HGH)
4.1.4 Granulocyte- Colony Stimulating Factor (G-CSF)
4.1.5 Monoclonal Antibody (mAb)
4.1.6 Insulin
4.1.7 Interferon (IFN)
4.1.8 Others
4.2 By Type - Global Monoclonal antibodies (mAbs) Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Monoclonal antibodies (mAbs) Biosimilars Revenue, 2017-2022
4.2.2 By Type - Global Monoclonal antibodies (mAbs) Biosimilars Revenue, 2023-2028
4.2.3 By Type - Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Monoclonal antibodies (mAbs) Biosimilars Market Size, 2021 & 2028
5.1.2 Anti-Cancer
5.1.3 Anti-Inflammatory/Autoimmune
5.2 By Application - Global Monoclonal antibodies (mAbs) Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Monoclonal antibodies (mAbs) Biosimilars Revenue, 2017-2022
5.2.2 By Application - Global Monoclonal antibodies (mAbs) Biosimilars Revenue, 2023-2028
5.2.3 By Application - Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Monoclonal antibodies (mAbs) Biosimilars Market Size, 2021 & 2028
6.2 By Region - Global Monoclonal antibodies (mAbs) Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Monoclonal antibodies (mAbs) Biosimilars Revenue, 2017-2022
6.2.2 By Region - Global Monoclonal antibodies (mAbs) Biosimilars Revenue, 2023-2028
6.2.3 By Region - Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Monoclonal antibodies (mAbs) Biosimilars Revenue, 2017-2028
6.3.2 US Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.3.3 Canada Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.3.4 Mexico Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Monoclonal antibodies (mAbs) Biosimilars Revenue, 2017-2028
6.4.2 Germany Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.4.3 France Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.4.4 U.K. Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.4.5 Italy Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.4.6 Russia Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.4.7 Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.4.8 Benelux Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Monoclonal antibodies (mAbs) Biosimilars Revenue, 2017-2028
6.5.2 China Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.5.3 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.5.4 South Korea Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.5.5 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.5.6 India Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Monoclonal antibodies (mAbs) Biosimilars Revenue, 2017-2028
6.6.2 Brazil Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.6.3 Argentina Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Revenue, 2017-2028
6.7.2 Turkey Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.7.3 Israel Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.7.4 Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
6.7.5 UAE Monoclonal antibodies (mAbs) Biosimilars Market Size, 2017-2028
7 Players Profiles
7.1 Biocon
7.1.1 Biocon Corporate Summary
7.1.2 Biocon Business Overview
7.1.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Major Product Offerings
7.1.4 Biocon Monoclonal antibodies (mAbs) Biosimilars Revenue in Global Market (2017-2022)
7.1.5 Biocon Key News
7.2 Celltrion
7.2.1 Celltrion Corporate Summary
7.2.2 Celltrion Business Overview
7.2.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Major Product Offerings
7.2.4 Celltrion Monoclonal antibodies (mAbs) Biosimilars Revenue in Global Market (2017-2022)
7.2.5 Celltrion Key News
7.3 Dr. Reddy's Laboratories
7.3.1 Dr. Reddy's Laboratories Corporate Summary
7.3.2 Dr. Reddy's Laboratories Business Overview
7.3.3 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Major Product Offerings
7.3.4 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Revenue in Global Market (2017-2022)
7.3.5 Dr. Reddy's Laboratories Key News
7.4 Hospira
7.4.1 Hospira Corporate Summary
7.4.2 Hospira Business Overview
7.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Major Product Offerings
7.4.4 Hospira Monoclonal antibodies (mAbs) Biosimilars Revenue in Global Market (2017-2022)
7.4.5 Hospira Key News
7.5 3SBio
7.5.1 3SBio Corporate Summary
7.5.2 3SBio Business Overview
7.5.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Major Product Offerings
7.5.4 3SBio Monoclonal antibodies (mAbs) Biosimilars Revenue in Global Market (2017-2022)
7.5.5 3SBio Key News
7.6 Accord Healthcare
7.6.1 Accord Healthcare Corporate Summary
7.6.2 Accord Healthcare Business Overview
7.6.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Major Product Offerings
7.6.4 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Revenue in Global Market (2017-2022)
7.6.5 Accord Healthcare Key News
7.7 AET Biotech
7.7.1 AET Biotech Corporate Summary
7.7.2 AET Biotech Business Overview
7.7.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Major Product Offerings
7.7.4 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Revenue in Global Market (2017-2022)
7.7.5 AET Biotech Key News
7.8 Allergan
7.8.1 Allergan Corporate Summary
7.8.2 Allergan Business Overview
7.8.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Major Product Offerings
7.8.4 Allergan Monoclonal antibodies (mAbs) Biosimilars Revenue in Global Market (2017-2022)
7.8.5 Allergan Key News
7.9 Amega Biotech
7.9.1 Amega Biotech Corporate Summary
7.9.2 Amega Biotech Business Overview
7.9.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Major Product Offerings
7.9.4 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Revenue in Global Market (2017-2022)
7.9.5 Amega Biotech Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Monoclonal antibodies (mAbs) Biosimilars Market Opportunities & Trends in Global Market
Table 2. Monoclonal antibodies (mAbs) Biosimilars Market Drivers in Global Market
Table 3. Monoclonal antibodies (mAbs) Biosimilars Market Restraints in Global Market
Table 4. Key Players of Monoclonal antibodies (mAbs) Biosimilars in Global Market
Table 5. Top Monoclonal antibodies (mAbs) Biosimilars Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Companies, 2017-2022
Table 8. Global Companies Monoclonal antibodies (mAbs) Biosimilars Product Type
Table 9. List of Global Tier 1 Monoclonal antibodies (mAbs) Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monoclonal antibodies (mAbs) Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Monoclonal antibodies (mAbs) Biosimilars Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Monoclonal antibodies (mAbs) Biosimilars Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Monoclonal antibodies (mAbs) Biosimilars Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Monoclonal antibodies (mAbs) Biosimilars Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2023-2028
Table 30. Biocon Corporate Summary
Table 31. Biocon Monoclonal antibodies (mAbs) Biosimilars Product Offerings
Table 32. Biocon Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), (2017-2022)
Table 33. Celltrion Corporate Summary
Table 34. Celltrion Monoclonal antibodies (mAbs) Biosimilars Product Offerings
Table 35. Celltrion Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), (2017-2022)
Table 36. Dr. Reddy's Laboratories Corporate Summary
Table 37. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Product Offerings
Table 38. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), (2017-2022)
Table 39. Hospira Corporate Summary
Table 40. Hospira Monoclonal antibodies (mAbs) Biosimilars Product Offerings
Table 41. Hospira Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), (2017-2022)
Table 42. 3SBio Corporate Summary
Table 43. 3SBio Monoclonal antibodies (mAbs) Biosimilars Product Offerings
Table 44. 3SBio Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), (2017-2022)
Table 45. Accord Healthcare Corporate Summary
Table 46. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Product Offerings
Table 47. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), (2017-2022)
Table 48. AET Biotech Corporate Summary
Table 49. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Product Offerings
Table 50. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), (2017-2022)
Table 51. Allergan Corporate Summary
Table 52. Allergan Monoclonal antibodies (mAbs) Biosimilars Product Offerings
Table 53. Allergan Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), (2017-2022)
Table 54. Amega Biotech Corporate Summary
Table 55. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Product Offerings
Table 56. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Monoclonal antibodies (mAbs) Biosimilars Segment by Type in 2021
Figure 2. Monoclonal antibodies (mAbs) Biosimilars Segment by Application in 2021
Figure 3. Global Monoclonal antibodies (mAbs) Biosimilars Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Monoclonal antibodies (mAbs) Biosimilars Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Monoclonal antibodies (mAbs) Biosimilars Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2021
Figure 8. By Type - Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
Figure 9. By Application - Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
Figure 10. By Region - Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
Figure 11. By Country - North America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
Figure 12. US Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
Figure 16. Germany Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 17. France Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
Figure 24. China Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 28. India Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
Figure 30. Brazil Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, 2017-2028
Figure 33. Turkey Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Monoclonal antibodies (mAbs) Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 37. Biocon Monoclonal antibodies (mAbs) Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celltrion Monoclonal antibodies (mAbs) Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Hospira Monoclonal antibodies (mAbs) Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. 3SBio Monoclonal antibodies (mAbs) Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Allergan Monoclonal antibodies (mAbs) Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
